ARONJ--a spectrum disorder?

J Am Dent Assoc. 2012 Jul;143(7):739-40; author reply 740-1. doi: 10.14219/jada.archive.2012.0252.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw / prevention & control*
  • Bone Density Conservation Agents / therapeutic use*
  • Humans
  • Osteoporosis / drug therapy*

Substances

  • Bone Density Conservation Agents